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Aim: To compare microvascular reactivity assessed in the skin using laser Doppler fluximetry (LDF) in women with
gestational diabetes mellitus (GDM) and gestational age-matched control during pregnancy.
Methods: 110 pregnant women at ~33 weeks gestation participated in the study. Skin microvascular reactivity was
evaluated by LDF, at rest, during the response to brief arterial occlusion (post occlusive hyperaemic response) and
during sympathetically mediated vasoconstrictor response to deep inspiratory breath hold.
Results: No statistically significant differences were found in the microvascular variables studied (resting and maximum
rate flux, post-ischaemic reactive hyperaemia and deep inspiratory breath holds) between +GDM and –GDM groups
women. In women with GDM there was a negative correlation between resting flux and the response to the oral
glucose tolerance test (OGTT), r = -0.282 (p = 0.037). There was also a negative correlation between the response to the
OGTT and the sympathetically mediated constrictor response to inspiratory breath holds (r = -.298, p = .030) but not in
women with GDM (r = .102, r = .468).
Conclusion: Attenuated microvascular reactivity as an early marker of endothelial dysfunction is not present in women
with GDM when assessed during pregnancy.
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Concurrent with the rising prevalence of obesity, espe-
cially among women of reproductive age, the prevalence
of gestational diabetes mellitus (GDM) is increasing and
has been a health concern worldwide [1]. GDM is asso-
ciated with adverse perinatal outcomes for both mother
and fetus [2]. GDM women and their offspring are more
likely to be obese and have insulin resistance throughout
life [3]. Women with a history of GDM have a 70%
higher incidence of cardiovascular disease (CVD) as
compared to their peers and even milder gestational im-
paired glucose tolerance has been associated with an en-
hanced cardiovascular risk factor profile and subsequent
type 2 diabetes [4,5].
Endothelium dysfunction has been indicated as an
early event in the development of CVD and the main
underlying mechanism of type 2 diabetes complications* Correspondence: joaoguilherme@imip.org
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unless otherwise stated.in the peripheral and microvasculature [6]. Microvascu-
lar complications represent the main cause of morbidity
and mortality in diabetes mellitus. Microvascular abnor-
malities and impaired tissue perfusion are associated with
insulin resistance and may precede the clinical manifesta-
tions of diabetic microvascular disease and macrovascular
dysfunction [7]. Endothelial dysfunction has been showed
as an early and accurate predictor of long-term cardiovas-
cular events in patients with diabetes [8].
Impaired endothelium-dependent relaxation in larger
blood vessels has been observed in women with a history
of GDM assessed months or years after delivery in some
but not all studies and these findings remain controver-
sial [9-12]. Similarly, impaired microvascular responses
have also been reported in women with previous GDM
studied some years after pregnancy [11,13] suggesting
that abnormal microvascular function could represent a
novel mechanism contributing to the elevated risk of
CVD in these women. However, microvascular responses
have yet to be fully evaluated during pregnancy in
women newly diagnosed with GDM.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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reproducible method with which to investigate micro-
vascular function in the skin [14,15]. It has been widely
used in a clinical setting combined with provocation tests
to investigate vascular mechanism in hypertension [16],
obesity [17] and in diabetes [18]. Several studies have
shown skin microvascular reactivity to be attenuated in in-
sulin resistant individuals and in individuals with type 1
and type 2 diabetes compared with control [14,17,19].
This study aims to compare microvascular reactivity
assessed in the skin using LDF in women with GDM
and gestational age-matched controls during pregnancy
and to explore the association between microvascular re-
activity and other CVD risk factors in these women.
Material and methods
A cross-sectional study enrolled 110 pregnant women,
55 with GDM diagnostic and 55 normoglycemic. All
study participants were recruited from the prenatal care
of Instituto de Medicina Integral Prof. Fernando Figueira
(IMIP) from September 2013 to August 2014. This pro-
ject was previously approved by the Ethics Committee
(n°: 02345112.6.0000.5201) in Research of IMIP and all
pregnant women signed an informed consent form.
GDM diagnosis was based on the International Associ-
ation of Diabetes and Pregnancy Study Group [20] cri-
teria. A glucose tolerance test (OGTT) was performed
between 24th and 28th gestational week with a 75 g of
dextrose; a fasting glucose ≥ 92 mg/dl, or 1 h post-test
≥180 mg/dl or 2 h post-test ≥ 153 mg/dl were all consid-
ered as gestational diabetic criteria. Pregnant women
with previous history of GDM, type 1(T1D) or type 2
diabetes (T2D), hypertensive disorder and mental or
neurologic disease were excluded. Anthropometric and
obstetrical variables were collected by an interviewer.
Body mass index (BMI) was based on the Atalah et al.
[21] curve for gestational week. The gestational age was
derived from the last menstrual period, otherwise, gesta-
tional age was corrected on the basis of ultrasonographic
measurements.
Skin microvascular reactivity was evaluated by LDF at
approximately 28 weeks gestation using a 785 nm,
1 mW low power red laser light source (VMS-Moor In-
struments, UK). Single point laser Doppler flow probes
(DP1T, Moor, Instruments, UK) were attached to the
skin using double-sided sticky O-rings, one on the volar
surface of the left forearm approximately 10 cm from
the wrist and avoiding visible veins, and one on the pulp
of the middle finger of the same arm.
All tests were conducted after a period of acclimatiza-
tion in a temperature-controlled room (23°C ± 1°C), with
the participants sitting comfortably with their arms rest-
ing at heart level and legs elevated. Participants were
instructed not to take exercise or to consume caffeinateddrinks in the 24 hours that preceded the evaluation. All
tests were performed by the same researcher.
Baseline skin perfusion flux was continuously recorded
for up to 10 min prior to perturbation of skin blood
flow. Skin microvascular reactivity was assessed (a) dur-
ing and for 5 min after the hyperemic response to brief
arterial occlusion (200 mmHg for 3 min) using a pres-
sure cuff placed around the upper arm (VMSPRES Moor
Instruments, UK) [15], and (b) in response to transient
sympathetic nervous system-mediated vasoconstriction
to deep inspiratory breath hold (IBH) (3 × 6 second deep
inspiratory breath holds with 1 min between each) [22]
(Figure 1). Data were stored for later analysis using the
manufacturer’s software.
The variables analyzed to evaluate the microvascular
dilator capacity at the forearm were resting flux (RF, in
arbitrary perfusion units PU) measured as the average
flux over the 5 min before cuff inflation; maximum flux
(MF, PU) during the post occlusive hyperemic (PORH)
response; and the ratio of MF to RF (Figure 1A). The
area under the hyperemia response was also estimated.
The vasoconstrictor response to IBH was taken from the
flux recorded at the finger as the minimum value over
the last 3 seconds of the breath hold and expressed as %
change from baseline of the mean minimum response
for the three breath holds [22] (Figure 1B).
Data analysis was performed using SPSS 13.0 for
Windows. Measures of central tendency and dispersion
for numeric variables were obtained. Data were tested
for normality using a Kolmogorov-Smirnov test for
quantitative variables. Data are reported as means and
standard deviations (mean ± SD) for normally distributed
variables, or as median and interquartile range (IQR) for
non-normally distributed variables. Comparison of mea-
surements in women with and without GDM for con-
tinuous variables was undertaken by paired t-tests or
Mann-Whitney test. Pearson and Spearman rank correl-
ation coefficients were used to investigate associations
between normally and non-normally distributed vari-
ables, respectively. In all cases a value of p < 0.05 was
taken to indicate significance.
Results
198 pregnant women were enrolled in the study and 144
were eligible; 54 were excluded by blood hypertension,
type 1 or type 2 diabetes or twin pregnancy. From the
eligible pregnant women, 34 did not agree to participate.
The final sample consisted of 110 pregnant women, 55
with GDM and 55 controls. Among the 55 GDM preg-
nant women, 4 were taking medication for hypergly-
cemia control and 51 were controlled with an adequate
diet.
Women were studied during week 33 ± 4 of pregnancy.
The women had an average age of 27.5 ± 6 years and
Figure 1 Representative recording of blood flux from the skin of the forearm and finger measured using laser Doppler fluximetry.
A. RF = resting blood flux, MF = maximum flux on release of arterial occlusion at forearm (200 mmHg for 3 min). B. Baeline and minimum flux
measured at the finger over the last 3 sec of three 6 second inspiratory breath holds.
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the whole cohort, BMI at the time of study was posi-
tively correlated with systolic (r = 0.261, p = 0.006) and
diastolic (r = 0.239, p = 0.012) blood pressure and with
fasting glucose (r = 0.213, p = 0.026). Age was positively
correlated with the response to the OGTT at both 1 h
(r = 0.417, p < 0.001) and 2 h (r = 0.316, p < 0.001).
Table 1 summarizes the anthropometric and obstetric
characteristics of the two groups of women with and
without GDM. Women with GDM were significantly
older with a higher BMI than women without GDM.
Primiparous prevalence showed no difference among
women with and without GDM and was 54.5% and
57.4%, respectively.
No statistically significant differences were found in
the microvascular variables studied at the forearm (RF,
MF, MF/RF, area under the hyperaemic response curve)
between +GDM and –GDM groups (Table 2). There was
a negative correlation between resting forearm flux and
the response to the OGTT at 2 h (r = -0.282, p = 0.037)
women with GDM (Figure 2). In women without GDM
the response to the OGTT and resting forearm blood flux
was positively correlated (r = 0.296, p = 0.030). Baselineflux measured at the finger was lower in women with
GDM (p = 0.026) and correlated with weight gain during
pregnancy (r = 0.330, p = 0.014). There was also a negative
correlation between the response to the OGTT at 1 h and
the sympathetically mediated constrictor response to IBH
(%IBH) (r = -0.298, p = 0.030) in women without GDM
but not in women with GDM (r = 0.102, r = 0.468).Discussion
In this study we found no differences in microvascular
reactivity between women with and without GDM when
assessed during pregnancy. In women without GDM
glucose homeostasis was associated positively with rest-
ing skin blood flux and negatively with sympathetically
mediated vascular tone, both of which adaptive re-
sponses were lost in women with GDM. In women with
GDM we found a negative correlation between resting
skin microvascular blood flux and glucose homeostasis.
Across the whole study cohort there was a relationship
between glucose homeostasis and age, pregnancy BMI
and weight gain, but not microvascular status. Together
these data suggest that there is no impairment in
Table 1 Anthropometric and obstetric variables of








Age (years) 29.5 ± 6.5 25.6 ± 4.7 <0.001a
Gestational age at study 33.2 (3.7) 32.9 (3.8) 0.550b
Height (cm) 160.6 (7.6) 157.9 (7.2) 0.312b
Weight before pregnancy (kg) 68.0 ± 15.7 63.5 ± 9.6 0.072a
Weight at test (kg) 77.8 ± 15.0 73.9 ± 9.7 0.114a
Weight gain (kg) 9.8 ± 5.2 10.0 ± 4.4 0.772a
BMI before pregnancy (kg/m2) 26.2 ± 4.9 24.2 ± 3.3 0.014a
BMI at test (kg/m2) 30.0 ± 4.6 28.2 ± 3.2 0.017a
Fasting plasma glucose (mg/dl) 95.8 ± 18.9 81.1 ± 6.2 <0.001a
Plasma glucose after 1 h
OGGT (mg/dl)
166.4 ± 30.3 125.2 ± 18.5 <0.001a
Plasma glucose after 2 h
OGTT (mg/dl)
156.1 ± 33.2 109.5 ± 17.4 <0.001a
Systolic blood pressure (mmHg) 104.4 (10.3) 106.8 (7.2) 0.186b
Diastolic blood pressure (mmHg) 67.0 (9.2) 67.9 (6.8) 0.616b
Date are mean ± SD or median(IQR) aStudent t Test bTest Mann-Whitney test.
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diagnosed with GDM and studied in the 3rd trimester.
Previous studies have shown that in women with a his-
tory of gestational diabetes endothelial dysfunction is
present in forearm conduit arteries [10,11,13] and that
these women have a high risk of developing vascular dis-
ease and type 2 diabetes, despite normalization of hyper-
glycemia after delivery [23]. Most studies that have
explored endothelium function in women with GDM
have assessed vascular function at the level of the
macrovasculature months to years after delivery. Vascu-
lar dysfunction seen in the early post-partum period inTable 2 Skin blood flux measured by laser Doppler
fluximetry in women with and without gestational diabetes
mellitus GDM (n = 55 per group)
Group
Variables +GDM –GDM p-value
Resting Forearm Flux (RF, PU) 9.7 ± 2.7 9.6 ± 3.5 0.779a
Maximum Forearm Flux (MF, PU) 64.2 ± 23.9 64.8 ± 36.1 0.917a
MF/RF 6.9 (2.5) 6.9 (2.9) 0.540b
Area of Hyperemia (PU.s) 14450 ± 718 1293 ± 824 0.297a
Baseline Finger Flux (PU) 279.1 ± 78.8 323.6 ± 96.7 0.026a
Minimum IBH Finger flux (PU) 138.4 ± 59.1 158.8 ± 85.5 0.152a
IBH change from baseline (%) 48.8 ± 20.8 49.4 ± 27.3 0.896a
Data are mean ± SD or median(IQR) aStudent t test bMann-Whitney test.
Values were obtained before and during the reactive hyperaemic response to
arterial occlusion at the forearm and deep inspiratory breath hold (IBH) at
the finger.previously GDM women has been taken to be indicative
of the potential for short term exposure to hypergly-
caemia to have long-term consequences on cardiometa-
bolic health [13]. However, it remains uncertain whether
endothelial dysfunction is present at the time of diagno-
sis of GDM or whether early attenuation in microvascu-
lar perfusion capacity may be contributory to later risk
of developing hypertension and T2D. Indeed endothe-
lium dysfunction has been detected in the fetoplacental
circulation in GDM [24]. Thus it is possible that very
early deficits in the microvasculature may contribute to
poor pregnancy outcomes.
To our knowledge this is the first study in which
microvascular reactivity, investigated as both dilator and
constrictor responses in the skin, has been evaluated in
women with GDM during pregnancy. We observed a
negative correlation between resting skin blood flow and
glycaemic control (plasma glucose levels at 1 and 2 h
post-test). This finding is consistent with that of Mrizak
et al [24] who showed a negative correlation between in-
sulin resistance (HOMA-IR) and microvascular reactiv-
ity; and supportive of a pathophysiological link between
GDM, type 2 diabetes and metabolic syndrome.
Our data indicate that when assessed during preg-
nancy, neither resting skin microvascular blood flow nor
dilator capacity to a short ischemic insult differed in
women matched for gestational age, with and without
GDM. Our finding of a lack of difference in vascular re-
activity between non-obese women with and without
GDM is consistent with those of Brewster et al [12] and
Hannemann et al [11] who found no evidence of endo-
thelial dysfunction assessed in the brachial artery using
flow mediated dilation (FMD) in women with previous
GDM studied 1-10 y postpartum. Davenport et al [13]
conversely found decreased endothelial function assessed
by FMD in women eight weeks after delivery. Our findings
in the microvasculature of a lack of difference between
women with and without GDM contrast with those of
Hannemann et al. [11] who in the same group of women
in which they report no different in FMD, studied up to
10 years after pregnancy showed impairment of the max-
imal hyperaemia to local warming in the skin microvascu-
lature. They also contrast with Hu et al [25] who reported
a reduced cutaneous ACh-mediated dilation in .the hands
and feet of asymptomatic women with a history of GDM,
2 to 4 years after pregnancy. While some of these differ-
ences may be due to the part of the vascular tree studied,
brachial artery vs microcirculation, the differences ob-
served within the same vascular bed (the skin microvascu-
lature) albeit of the forearm, hands and feet, are less easily
resolved. It may be speculated that when studied at the
time of diagnosis there has been insufficient time for the
hyperglycaemic state to impact on endothelial function. The
attenuated vascular responses and endothelial dysfunction
Figure 2 Scatter plots showing the relationship between resting forearm blood flux measured using laser Doppler fluximetry and
glycaemic response to an oral glucose tolerance test (OGTT) measured at 2 hours in women with and without gestational diabetes
mellitus (GDM) performed between 24th and 28th gestational week. +GDM r = -0.282, p = 0.037; –GDM r = 0.296, p = 0.030.
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consequence of the persistence of clinical and/or subclin-
ical hyperglycemia after delivery and the subsequent de-
velopment of vascular complications that predispose to
increased CVD risk and the development of NIDDM.
Factors additional to dysglycaemia during pregnancy
may also contribute to later endothelial dysfunction.
These include an increased inflammatory state [26] dem-
onstrated to be negatively correlated with skin blood
flow in women with GDM [27]. These authors report an
attenuated endothelium-dependent ACh-mediated vaso-
dilation measured in the skin of the forearm using LDF,
in no-obese GDM women, studied similarly to us in the
third trimester of pregnancy. An altered PORH response
has also been reported in pregnant hypercholesterolae-
mic patients compared with age and gestational age-
matched controls [28]. We were unable to measure
markers of inflammatory status or cholesterol in our co-
hort, but cannot rule out the possibility that these fac-
tors may contribute to altered microvascular reactivity
in GDM.
Pregnancy is associated with positive cardiovascular
adaptations including a decreased total peripheral resist-
ance (TPR) designed to promote the convective delivery
of oxygen and nutrients to the developing fetus [29].
The values of resting skin blood flux and the changes in
microvascular flux during PORH and IBH are consistent
with those reported previously by us and others in simi-
larly aged cohorts [13,14] and there was no correlation
with blood pressure. It is possible however that the dif-
fering direction of the associations between glycaemic
control and sympathetically-mediated vasoconstrictor
response in the two groups of women may be contribu-
tory to the development of dysglycaemia and GDM in
some women. There are considerations that must be
taken into account when interpreting these data. Current
BMI, pre-pregnancy BMI and age were higher in women
with GDM, all of which are recognized risk factors forGDM [30]. The mean age of the +GDM group was also
4 years greater than –GDM. Altered microvascular re-
activity has been shown to be associated with metabolic
phenotype and with age [14]. Thus it is surprising that
we did not see differences in any of our microvascular
measures between the two groups. Glucose levels were
being managed in the majority of our GDM patients by
diet or medicines which may contribute to the lack of
difference in microvascular reactivity between the two
study groups. We did not measure insulin or lipopro-
teins profile which have been described as associated
with endothelium function. The study was a cross-
sectional study design and we were unable to explore
the progression of changes in microvascular reactivity
post partum.
Conclusion
We concluded that microvascular reactivity is unaltered
in women with GDM when assessed during pregnancy.
Thus despite changes in endothelial function that are
seen postpartum in women with previous gestational
dysglycaemia and their long term cardiovascular risk, it
is unlikely that early changes in microvascular function
contribute to this. Additional factors such as maternal
obesity and weight gain during pregnancy that are asso-
ciated with microvascular dysfunction across the study
cohort may play a greater role in predisposing to later
risk of developing vascular disease and type 2 diabetes.
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